Micron Technology, Inc. (MU) Post Earnings Q4 2024 Earnings Call Transcript
https://seekingalpha.com/article/4723334-micron-technology-inc-mu-post-earnings-q4-2024-earnings-call-transcript?source=feed_sector_transcripts
Sep 25, 2024 - Micron Technology, Inc. (NASDAQ:MU) Q4 2024 Post Earnings Conference Call September 24, 2024 5:00 PM ETCompany ParticipantsSatya Kumar - IRSumit Sadana -...
0
U.S. Stocks Close Slightly Higher; Dow, S&P Post New Highs
https://www.rttnews.com/story.aspx?Id=3476852
Sep 23, 2024 - U.S. stocks closed higher on Monday and the Dow and S&P 500 posted record highs, although the gains were just marginal, as investors largely made cautious moves ahead of some crucial economic data and Fed speeches.
0
Mizuho recommends buying Corbus following its drop post-Novo's obesity data
https://seekingalpha.com/news/4151904-mizuho-recommends-buying-corbus-following-its-drop-post-novos-obesity-data?source=feed_sector_healthcare
Sep 23, 2024 - Financial writer recommends buying Corbus Pharmaceutical (CRBP) after stock plunges on Novo Nordisk's obesity drug data.
0
Oil posts best week in six but China concerns aren't going away
https://seekingalpha.com/news/4151740-oil-posts-best-week-in-six-but-china-concerns-arent-going-away?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Sep 20, 2024 - Oil futures rose for the week but lower on the day, impacted by the Fed's rate cut and tensions in the Middle East.
0
Aligos posts initial mid-stage trial results for MASH candidate
https://seekingalpha.com/news/4151081-aligos-stock-falls-data-mash-candidate?source=feed_sector_healthcare
Sep 19, 2024 - Aligos Therapeutics (ALGS) stock slips as company releases Phase 2a results for liver drug ALG-055009 in MASH. Read more here.
0
Stocks Higher, Dollar Lower Post Fed's Rate Cut
https://seekingalpha.com/article/4722041-stocks-higher-dollar-lower-post-feds-rate-cut?source=feed_tag_forex
Sep 19, 2024 - The Federal Reserve's 50 bp rate cut has made for a volatile 15 hours or so in the foreign exchange market. Click to read.
0
GSK posts late-stage trial win for co-administered RSV and shingles vaccines
https://seekingalpha.com/news/4150869-gsk-posts-trial-win-rsv-shingles-shots?source=feed_sector_healthcare
Sep 18, 2024 - GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix. Read more here.
0
Private-label grocery brands boomed during inflation. Prices are down, but store-brand items keep going higher
https://www.cnbc.com/2024/09/16/future-of-supermarket-store-brands-after-end-of-war-on-inflation.html
Sep 16, 2024 - Inflation and price hikes sent grocery bills soaring to their highest level in decades, and private store brands to boom. Their shelf space may be permanent.
0
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
https://www.fool.com/investing/2024/09/15/down-more-than-50-is-it-time-to-buy-moderna-stock/?source=iedfolrf0000001
Sep 15, 2024 - This highflier has fallen on hard times recently.
0
Dogecoin Barks Higher Today on New Musk Post
https://www.fool.com/investing/2024/09/13/dogecoin-barks-higher-today-on-new-musk-post/?source=iedfolrf0000001
Sep 13, 2024 - Dogecoin is once again on the move higher today, surging more than 5% on fresh comments from Tesla CEO Elon Musk.
0